Modified LDL decreases the binding of prostaglandin E2, I2, and E1 onto monocytes in patients with peripheral vascular disease

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 17, Issue 10, 1997, Pages 2066-2073

  Li, S R ^a   Yang, Q ^b   Koller, E ^a   Kurtaran, A ^a   Bischof, C ^a   Leimer, M ^a   Rauscha, F ^a   Pidlich, J ^a   Virgolini, I ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b NONE

Author keywords

Arteriosclerosis; HDL; LDL; Modified LDL; Monocytes

Indexed keywords

LOW DENSITY LIPOPROTEIN; PROSTACYCLIN; PROSTAGLANDIN E1; PROSTAGLANDIN E2;

ADULT; AGED; ARTERIOSCLEROSIS; ARTICLE; ATHEROGENESIS; BINDING AFFINITY; CELL FUNCTION; CLINICAL ARTICLE; DRUG RECEPTOR BINDING; FEMALE; HUMAN; LIGAND BINDING; MACROPHAGE; MALE; MONOCYTE; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; RECEPTOR AFFINITY;

EID: 0031470989     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.17.10.2066     Document Type: Article

References (15)

1. Bylock AL, Gerrity RG. Visualization of monocyte recruitment into atherosclerotic arteries using fluorescent labeling. Atherosclerosis. 1988;71:17-25.
2. Gerrity RG. The role of the monocyte in atherosclerosis, I: transition of blood-borne monocytes into foam cells in fatty lesions. Am J Pathol. 1981;103:181-190.
3. Goldstein JL, Ho YK, Basu SK, Brown MS. Binding sites on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. Proc Natl Acad Sci U S A. 1979;76:333-337.
4. Brown MS, Goldstein JL, Krieger M, Ho YK, Anderson RGW. Reversible accumulation of cholesterol esters in macrophages incubated with acetylated lipoproteins. J Cell Biol. 1979;82:597-613.
5. Humes JL, Bonney RJ, Pelus L, Dahlgren ME, Sadowski SL, Kuehl FA, Davies P. Macrophages synthesize and release prostaglandins in response to inflammatory stimuli. Nature. 1977;269:149-150.
6. Scott WA, Pawlowski NA, Murray HW, Andreach M, Zrike J, Cohn ZA. Regulation of arachidonic acid metabolism by macrophage activation. J Exp Med. 1982;155:1148-1160.
7. Tripp CS, Wyche A, Unanue ER, Needleman P. The functional significance of the regulation of macrophage I. expression by endogenous arachidonate metabolites in vitro. J Immunol. 1986;137: 3915-3920.
8. 2 receptor. J Biol Chem. 1992;267:12700-12708.
9. 1 binding capacity. Br J Cancer. 1989;59:407-409.
10. 1/prostacyclin receptor of human blood platelets. J Biol Chem. 1987;262:12685-12691.
11. Li SR, Yang Q, Wandl E, Pirker W, Virgolini I. Acetyl-salicylic acid (ASA) protects the prostaglandin-cAMP-system of human hypernephroma cells against irradiation-induced alterations. Br J Cancer. 1993;68:695-701.
12. 2 receptor on human peripheral blood monocytes. Scand J Immunol. 1985;21:167-172.
13. 2 on rat peritoneal macrophages. Biochem Biophys Res Commun. 1983;114:155-161.
14. Fernandez-Botran R, Suzuki T. Properties of prostaglandinsensitive adenylate cyclase system of a murine macrophage-like cell line (P388D1).J Immunol. 1984;133:2655-2661.
15. 2 binding proteins. J Immunol. 1984;133:2662-2667.